Literature DB >> 16186472

Description of a new hepatitis C risk assessment tool.

Minhhuyen T Nguyen1, Steven K Herrine, Christine A Laine, Karen Ruth, David S Weinberg.   

Abstract

BACKGROUND: Because of the low prevalence of hepatitis C virus (HCV) infection in the general population, mass screening would be expensive and of low yield. Some researchers advocate targeted screening of persons at elevated HCV risk.
METHODS: This cross-sectional study aimed to develop a patient-administered tool to assess HCV infection risk. Two hundred seven patients with unknown HCV status from a general medicine practice and 222 HCV-positive patients from a hepatology practice completed a 72-item survey about demographic, social, and clinical risk factors for HCV infection. General medicine patients also underwent HCV serologic testing.
RESULTS: Three (1.5%) of 207 general medicine patients had positive HCV antibody test results. These patients plus the 222 hepatology patients were significantly more likely than HCV-negative patients to report an array of factors. In a multivariable model, 7 factors remained significantly associated with HCV infection: sex with a prostitute or an injecting drug user, exposure to blood products, refusal as a blood donor or as a life insurance applicant, witnessing illicit drug use, and self-reported HBV infection. A simplified model that assigned 1 point for each factor present predicted HCV infection as well as a weighted model (based on chi(2) testing and receiver operating characteristic curve comparison). In a population with a 2% prevalence of HCV infection, people who identified 2 risk factors had a 10% chance of HCV infection, whereas those with 4 or more risk factors had a 50% chance.
CONCLUSIONS: A self-administered 72-item questionnaire can stratify patients into HCV risk groups. If validated in other primary care populations, this instrument could help target HCV screening.

Entities:  

Mesh:

Year:  2005        PMID: 16186472     DOI: 10.1001/archinte.165.17.2013

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

2.  An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.

Authors:  Javier Martínez-Sanz; María Jesús Vivancos-Gallego; Borja Manuel Fernández-Felix; Alfonso Muriel; Pilar Pérez-Elías; Almudena Uranga; Beatriz Romero; Juan Carlos Galán; Santiago Moreno; María Jesús Pérez-Elías
Journal:  Microbiol Spectr       Date:  2022-03-31

3.  Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals.

Authors:  Kathleen A Brady; Mark Weiner; Barbara J Turner
Journal:  J Infect       Date:  2009-05-03       Impact factor: 6.072

4.  Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.

Authors:  Engy Mohamed El-Ghitany; Azza Galal Farghaly; Shehata Farag; Ekram Wassim Abd El-Wahab
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

5.  Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).

Authors:  Astrid M Newsum; Ineke G Stolte; Jan Tm van der Meer; Janke Schinkel; Marc van der Valk; Joost W Vanhommerig; Anne Buvé; Mark Danta; Arjan Hogewoning; Maria Prins
Journal:  Euro Surveill       Date:  2017-05-25

6.  Performance and modification of EGCRISC among hepatitis C virus high-risk groups.

Authors:  E M El-Ghitany; Y M Alkassabany; A G Farghaly
Journal:  Epidemiol Infect       Date:  2020-02-14       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.